URSA-PHARM | PDC Medication Adherence

Overview

Proportion of Days Covered ("PDC") measures the percent of days during an medication therapy episode with a positive supply of across three major medication types which are tracked in CMS Stars ratings; Oral Antidiabetics, Oral ACEI/ARBs, and Statins. This report introduces users to the concept of PDC, provides versions of these measures that are geared towards practice operations, and contains pre-built boards that show performance across populations, payors, and action lists of patients currently failing to meet the PDC target of 80% of days within an episode.

Use this report to

• Develop an understanding of the configuration of a PDC measure
• Analyze historical and monitor ongoing performance across PDCs for Oral Antidiabetics, Oral ACEI/ARBs, and Statins.
• Generate lists of patients requiring intervention to meet their PDC target.
• Measure the opportunity for deploying interventions such as 90-day fills to improve adherence.

Potential takeaways

• What is PDC performance across payors and plans?
• Which patients are falling below 80% of PDC?
• Which patients currently falling below 80% are redeemable for the 12 month measurement period?
• Which patients have multiple open episodes?
• Which providers are owning the prescriptions of these adherence medications?
• Who is/are the providers prescribing the medications for this episode and is it the PCP or another provider?
• What percent of PDC medications are being prescribed for a 90-day supply?
• Which providers/patients could be switched to a 90-day supply?

Measures included in this report

• URSA-PHARM-R08: Patients with Active PDC Medication
• URSA-PHARM-011: Admits per 1000 Chronic Med Member Years
• URSA-PHARM-012: ED Visits per 1000 Member-Years Chronic Meds
• URSA-PHARM-024b: Percent of PDC Fills for 90 Days Supply
• URSA-PHARM-101: Oral Antidiabetic PDC
• URSA-PHARM-102: Oral ACEI/ARB PDC
• URSA-PHARM-103: Statin PDC